Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response

Modern Pathology(2023)10.1016/j.modpat.2023.100165Source: DataRank Database

Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response is a research paper published in Modern Pathology (2023). On theSindex it has a DataRank of 0.564. It has been cited 42 times.

N/A

0.564DataRank · unranked

Scored on demand from live citation data

Open Access42 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: bronzeTopics (27)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.564

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (15)

Walid K. Chatila ORCID,Cecilia Lezcano ORCID,Christopher A. Febres‐Aldana,Nikolaus Schultz ORCID,Chad Vanderbilt ORCID

Live enrichment

PubMed:36990277 PMC:PMC10698871

National Cancer Institute

Grant: P30-CA008748

NCI NIH HHS

Grant: P30 CA008748

National Institutes of Health

Marie-Josée and Henry R. Kravis Center for Molecular Oncology

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttp://www.modernpathology.org/article/S0893395223000704/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0893395223000704?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0893395223000704?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10698871/pdf/nihms-1945926.pdf

Fields of Study

HumansImmune Checkpoint InhibitorsMelanomaSarcomaSoft Tissue NeoplasmsBiomarkers, TumorHistiocytoma, Malignant FibrousNeoplasms, Second PrimaryImmunotherapyMutationCutaneous Malignant Melanoma

MeSH Terms

HumansSarcomaMelanomaSoft Tissue NeoplasmsNeoplasms, Second PrimaryImmunotherapyMutationHistiocytoma, Malignant FibrousBiomarkers, TumorImmune Checkpoint InhibitorsCutaneous Malignant Melanoma

Keywords

Undifferentiated Pleomorphic SarcomaDedifferentiated MelanomaMutational SignatureImmunotherapy ResponseUndifferentiated Melanoma